Cell line · CVCL_S611
Papers13
1 to 13 of 13
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. | Commun Biol | 2024 | Its Methods give the RRID and name the line | PubMed | |
New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB. | Mol Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines. | Exp Cell Res | 2019 | Cellosaurus cites it | PubMed | |
| Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines. | Oncol Rep | 2018 | Cellosaurus cites it | PubMed | |
| Re-characterization of established human retinoblastoma cell lines. | Histochem Cell Biol | 2015 | Cellosaurus cites it | PubMed | |
| Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. | Lancet Oncol | 2013 | Cellosaurus cites it | PubMed | |
| Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. | Ophthalmology | 1991 | Cellosaurus cites it | PubMed | |
| Retinoblastoma cell lines Y79, RB355 and WERI-Rb27 are genetically related. | Ophthalmic Paediatr Genet | 1991 | Cellosaurus cites it | PubMed | |
| Newly established human retinoblastoma cell lines exhibit an "immortalized" but not an invasive phenotype in vitro. | Int J Cancer | 1990 | Cellosaurus cites it | PubMed | |
| In vitro differentiation of human retinoblastoma cells into neuronal phenotypes. | Differentiation | 1990 | Cellosaurus cites it | PubMed | |
| Mechanism of i(6p) formation in retinoblastoma tumor cells. | Cancer Genet Cytogenet | 1989 | Cellosaurus cites it | PubMed | |
| Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines. | Anticancer Res | 1989 | Cellosaurus cites it | PubMed | |
| A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. | Hum Genet | 1985 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_S611/papers